2012
DOI: 10.6026/97320630008357
|View full text |Cite
|
Sign up to set email alerts
|

Relevance of systems biological approach in the differential diagnosis of invasive lobular carcinoma & invasive ductal carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…These two sub-types show similarity in certain features such as tumour site, tumour size, stage and grade, but have different metastatic patterns, characteristic histology and malignant calcifications [5], [4]. IDC starts from ducts and spreads to the breast fatty tissue, whereas ILC is restricted to milk producing lobules [6]. These two sub-types are also discriminated at the molecular level with differential expression of gene encoding vimentin, cathespin D, thrombospondin, E-cadherin, vascular endothelial growth factor, cytokeratin 8, and cyclin A.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These two sub-types show similarity in certain features such as tumour site, tumour size, stage and grade, but have different metastatic patterns, characteristic histology and malignant calcifications [5], [4]. IDC starts from ducts and spreads to the breast fatty tissue, whereas ILC is restricted to milk producing lobules [6]. These two sub-types are also discriminated at the molecular level with differential expression of gene encoding vimentin, cathespin D, thrombospondin, E-cadherin, vascular endothelial growth factor, cytokeratin 8, and cyclin A.…”
Section: Introductionmentioning
confidence: 99%
“…[4], [7], [8], [9],[10], [11], [12]. The pathological differences between the two sub-types arises as a result of separate gene regulatory networks, which warrants further exploration for the development of appropriate diagnostic and therapeutic treatment strategy [6]. According to reports, 75% cases of invasive breast carcinoma cases are accounted by IDC, however, advanced treatment of IDC patients still remains a challenge due to lack of molecular targets for IDC treatment [13], [14].…”
Section: Introductionmentioning
confidence: 99%
“…These two sub-types show similarity in certain features such as tumour site, size, stage and grade, but have different metastatic patterns, characteristic histology and malignant calcifications 5,4 . IDC starts from ducts and spreads to the breast fatty tissue, whereas ILC is restricted to milk producing lobules 6 . These two sub-types are also discriminated at the molecular level with differential expression of gene encoding vimentin, cathepsin D, thrombospondin, E-cadherin, vascular endothelial growth factor, cytokeratin 8, and cyclin A 4,7-12 .…”
mentioning
confidence: 99%
“…These two sub-types are also discriminated at the molecular level with differential expression of gene encoding vimentin, cathepsin D, thrombospondin, E-cadherin, vascular endothelial growth factor, cytokeratin 8, and cyclin A 4,7-12 . The pathological differences between the two sub-types arises as a result of separate gene regulatory networks, which warrants further exploration for the development of appropriate diagnostic and therapeutic treatment strategy 6 . According to reports, 75% cases of invasive breast carcinoma cases are accounted by IDC, however, advanced treatment of IDC patients still remains a challenge due to lack of molecular targets for IDC treatment 13,14 .…”
mentioning
confidence: 99%